Ascend Wellness Holdings (AAWH) Return on Capital Employed (2021 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Return on Capital Employed came in at 2.11% in Q1 2026, down 273.0% year-on-year from 1.22% in Q1 2025, and up 57.09% quarter-over-quarter from 4.93% in Q4 2025.
Ascend Wellness Holdings (AAWH) Return on Capital Employed (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 2.11% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 273.0% year-over-year to 2.11% in Q1 2026; TTM through Mar 2026 was 2.11%, a 273.0% decrease from a year earlier, with the FY2025 full-year figure at 2.14%, down 276.0% from the prior year.
- Return on Capital Employed improved to 2.11% in Q1 2026 per AAWH's latest filing, from 4.93% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1.76% in Q3 2025 and bottomed at 4.93% in Q4 2025.
- The 5-year median for Return on Capital Employed is 0.0% (2022), against an average of 0.35%.
- Across the five-year window, Return on Capital Employed jumped 670 bps in 2022 and slumped 556 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 1.01% in 2022, then jumped by 56 bps to 0.44% in 2023, then jumped by 243 bps to 0.63% in 2024, then sank by 885 bps to 4.93% in 2025, then surged by 57 bps to 2.11% in 2026.
- Per Business Quant, the three latest AAWH Return on Capital Employed figures stand at 2.11% (Q1 2026), 4.93% (Q4 2025), and 1.76% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -2.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.11% |
| Dec 31, 2025 | -4.93% |
| Sep 30, 2025 | 1.76% |
| Jun 30, 2025 | 0.64% |
| Mar 31, 2025 | 0.61% |
| Dec 31, 2024 | 0.63% |
| Sep 30, 2024 | -0.10% |
| Jun 30, 2024 | 0.63% |
| Mar 31, 2024 | -0.16% |
| Dec 31, 2023 | -0.44% |
| Sep 30, 2023 | 0.15% |
| Jun 30, 2023 | 0.02% |
| Mar 31, 2023 | 0.99% |
| Dec 31, 2022 | -1.01% |
| Sep 30, 2022 | -1.95% |
| Jun 30, 2022 | -0.69% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -2.85% |
| Sep 30, 2021 | -2.21% |
| Jun 30, 2021 | -4.83% |